Research 2017-03-06T20:24:58+00:00

Research

  • Regression of Glioblastoma after Chimeric Antigen Receptor T-cell Therapy. December 29, 2016, Brown CE. Alizabeth D. StarrRet al, N Engl J Med 2016; 375: 2561-2569
  • City of Hope Researchers Achieve Remission using CAR-T cell therapy for Aggressive Brain Tumors Dec 28, 2016- Contract City of Hope, 626-409-9367 Denise Heady, or 626-218-6279, David Caovette
  • The PD-1 checkpoint pathway-Nov 3, 2016, V.A-Boussiotis etal. N Engl J Med 2016. 375; 1767- 1778
  • Neurosurgical treatment of brain tumors in the first 6 months of life: long term follow-up. Childs Nervous System. 2015; 31(12) 2283-2290
  • Chen L, Doc, Wang L, Yang C, Zhang JR, LiNetal. Human positive Coachivalor 4 (PC4) is involved in the progression and prognosis of astrocytoma. J Neurol Sci, 2014 Sept 19.
  • Tihan T, Essen, Qaddoumi I, Sughayer MA, Tolunay S, AL Hussaini M, etal. Pathologic Characteristics of pediatric intracranial pilocytic astrocytomas and their impact on outcome in 3 countries: a multi-institutional study. Am J. Sug Pathol. 2012 Jan. 36(1):43-55
  • Hales RK, Shokek, O, Burger PC, Paynter NP, chaichana KC, Quinones-Hinojosa A, etal. Prognostic factors in pediatric high-grade astrocytomas: the importance of accurate pathologic diagnosis. J Neurooncol. 2010 Aug.99(1):65-71
  • Initial management of Childhood Brain Tumors: Neurosurgical Considerations. J child neurology 2008 Oct; 23 (10): 1136-1148
  • Pollack IF, Hamilton RL, SoholvRW, etal. 06-methylguanine DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort. J Clin Oncol. 2006 Jul 0.24 (21):3431-7